Health care stocks edged higher Thursday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each increasing 0.1%.
The iShares Biotechnology ETF (IBB) eased 0.2%.
In corporate news, Eli Lilly (LLY) shares rose 2.8% after the company said it will increase the UK price of its weight-loss and type 2 diabetes drug Mounjaro starting in September for alignment with other developed countries.
Trinity Biotech (TRIB) shares surged 83% after the company said it received approval from the New York State Department of Health to start providing its PreClara Ratio biomarker test for the assessment of preeclampsia risk.
Philips (PHG) shares were down 0.6% after it said Thursday it plans to invest over $150 million in US manufacturing and research and development.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。